{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:09:47Z","timestamp":1778746187979,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2022-0222-01"],"award-info":[{"award-number":["2022-0222-01"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007631","name":"Chungnam National University Hospital","doi-asserted-by":"publisher","award":["2019-CF-032"],"award-info":[{"award-number":["2019-CF-032"]}],"id":[{"id":"10.13039\/501100007631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007631","name":"Chungnam National University Hospital","doi-asserted-by":"publisher","award":["2021-2129-01"],"award-info":[{"award-number":["2021-2129-01"]}],"id":[{"id":"10.13039\/501100007631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.clineuro.2023.107857","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T01:56:48Z","timestamp":1688003808000},"page":"107857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Vasodilatory effects of tadalafil in an animal model of cerebral vasospasm: Comparative analysis with oral nimodipine"],"prefix":"10.1016","volume":"232","author":[{"given":"Jin-Young","family":"Youm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bumsoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Hyon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young","family":"Il Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoung Soo","family":"Byoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeongwook","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clineuro.2023.107857_bib1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/jnnp-2014-307711","article-title":"The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage","volume":"85","author":"Budohoski","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.clineuro.2023.107857_bib2","first-page":"1711","article-title":"C. American Heart Association Stroke, R. Council on Cardiovascular, Intervention, N. Council on Cardiovascular, S. Council on Cardiovascular, Anesthesia, C. Council on Clinical","volume":"43","author":"Connolly","year":"2012","journal-title":"Guidel. Manag. aneurysmal subarachnoid hemorrhage: a Guidel. Healthc. Prof. Am. Heart Assoc. \/Am. Stroke Assoc., Stroke"},{"issue":"1","key":"10.1016\/j.clineuro.2023.107857_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1570159X17666190927113021","article-title":"Nimodipine reappraised: an old drug with a future","volume":"18","author":"Carlson","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.clineuro.2023.107857_bib4","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1016\/j.wneu.2019.08.008","article-title":"Changes of the Expression and Activity of Phosphodiesterase V in the Basilar Artery Before and After Cerebral Vasospasm in a Rabbit Model","volume":"132","author":"Huang","year":"2019","journal-title":"World Neurosurg."},{"issue":"4","key":"10.1016\/j.clineuro.2023.107857_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrd1362","article-title":"Tadalafil and vardenafil","volume":"3","author":"Neumeyer","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.clineuro.2023.107857_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1179\/016164102101200447","article-title":"Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model","volume":"24","author":"Inoha","year":"2002","journal-title":"Neurol. Res"},{"issue":"2","key":"10.1016\/j.clineuro.2023.107857_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.RES.70.2.248","article-title":"Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage","volume":"70","author":"Kim","year":"1992","journal-title":"Circ. Res"},{"issue":"9a","key":"10.1016\/j.clineuro.2023.107857_bib8","doi-asserted-by":"crossref","first-page":"9m","DOI":"10.1016\/S0002-9149(03)00824-5","article-title":"Overview of phosphodiesterase 5 inhibition in erectile dysfunction","volume":"92","author":"Rosen","year":"2003","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.clineuro.2023.107857_bib9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3171\/2020.1.JNS193107","article-title":"Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia","volume":"134","author":"Abulhasan","year":"2020","journal-title":"J. Neurosurg."},{"issue":"6","key":"10.1016\/j.clineuro.2023.107857_bib10","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/00006123-199806000-00031","article-title":"Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm","volume":"42","author":"Polin","year":"1998","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.clineuro.2023.107857_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0271678X17747177","article-title":"The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: a systematic review","volume":"38","author":"Pauls","year":"2018","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.clineuro.2023.107857_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainres.2006.08.028","article-title":"Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke","volume":"1118","author":"Zhang","year":"2006","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.clineuro.2023.107857_bib13","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1227\/01.NEU.0000245605.22817.44","article-title":"Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage","volume":"59","author":"Atalay","year":"2006","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.clineuro.2023.107857_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1124\/mol.66.1.144","article-title":"Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation","volume":"66","author":"Blount","year":"2004","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.clineuro.2023.107857_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00701-009-0540-x","article-title":"A new approach to the treatment of cerebral vasospasm: the angiographic effects of tadalafil on experimental vasospasm","volume":"152","author":"Koktekir","year":"2010","journal-title":"Acta Neurochir. (Wien. )"},{"issue":"Pt 2","key":"10.1016\/j.clineuro.2023.107857_bib16","first-page":"13","article-title":"The effect of phosphodiesterase inhibitor tadalafil on vasospasm following subarachnoid hemorrhage in an experimental rabbit model","volume":"110","author":"Narin","year":"2011","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1016\/j.clineuro.2023.107857_bib17","article-title":"Duration of vasodilatory action after intra-arterial infusions of calcium channel blockers in animal model of cerebral vasospasm","author":"Lim","year":"2020","journal-title":"Neurocrit Care"},{"issue":"4","key":"10.1016\/j.clineuro.2023.107857_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040187","article-title":"Enhanced Bioavailability of Tadalafil after Intranasal Administration in Beagle Dogs","volume":"10","author":"Kim","year":"2018","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.clineuro.2023.107857_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00003495-198937050-00004","article-title":"Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease","volume":"37","author":"Langley","year":"1989","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.clineuro.2023.107857_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00006123-199707000-00039","article-title":"Impairment of the modulatory role of nitric oxide on the endothelin-1-elicited contraction of cerebral arteries: a pathogenetic factor in cerebral vasospasm after subarachnoid hemorrhage?","volume":"41","author":"Alabadi","year":"1997","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.clineuro.2023.107857_bib21","first-page":"1188","article-title":"Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries","volume":"52","author":"Hansen-Schwartz","year":"2003","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.clineuro.2023.107857_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00701-003-0004-7","article-title":"Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage","volume":"145","author":"Woszczyk","year":"2003","journal-title":"Acta Neurochir. (Wien. )"},{"issue":"5","key":"10.1016\/j.clineuro.2023.107857_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178063","article-title":"Benzo[a]pyrene activates interleukin-6 induction and suppresses nitric oxide-induced apoptosis in rat vascular smooth muscle cells","volume":"12","author":"Tzeng","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clineuro.2023.107857_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/cvr\/cvm049","article-title":"Nitric oxide regulates vascular calcification by interfering with TGF- signalling","volume":"77","author":"Kanno","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.clineuro.2023.107857_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200411-1587OC","article-title":"Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells","volume":"172","author":"Wharton","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"4","key":"10.1016\/j.clineuro.2023.107857_bib26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00004647-200404000-00007","article-title":"Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage","volume":"24","author":"Zhou","year":"2004","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"10","key":"10.1016\/j.clineuro.2023.107857_bib27","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1161\/01.STR.0000141162.29864.e9","article-title":"Neurovascular protection reduces early brain injury after subarachnoid hemorrhage","volume":"35","author":"Park","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.clineuro.2023.107857_bib28","first-page":"26","article-title":"Impact of phosphodiesterase type 5 inhibitors on endothelial function","volume":"10","author":"Teloken","year":"2008","journal-title":"Rev. Urol."},{"issue":"34","key":"10.1016\/j.clineuro.2023.107857_bib29","doi-asserted-by":"crossref","first-page":"55863","DOI":"10.18632\/oncotarget.10150","article-title":"Cytoplasmic vacuolization in cell death and survival","volume":"7","author":"Shubin","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.clineuro.2023.107857_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.18388\/abp.2004_3579","article-title":"Physiology and pathophysiology of vascular signaling controlled by guanosine 3\u2032,5\u2032-cyclic monophosphate-dependent protein kinase","volume":"51","author":"Birschmann","year":"2004","journal-title":"Acta Biochim Pol."},{"issue":"5","key":"10.1016\/j.clineuro.2023.107857_bib31","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/01.CIR.95.5.1269","article-title":"cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway","volume":"95","author":"Yu","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.clineuro.2023.107857_bib32","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jtcvs.2008.10.016","article-title":"Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy","volume":"137","author":"Hirschberg","year":"2009","journal-title":"J. Thorac. Cardiovasc Surg."},{"issue":"4","key":"10.1016\/j.clineuro.2023.107857_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11906-006-0075-y","article-title":"Phosphodiesterase-5 inhibitors and their hemodynamic effects","volume":"8","author":"Prisant","year":"2006","journal-title":"Curr. Hypertens. Rep."},{"issue":"31","key":"10.1016\/j.clineuro.2023.107857_bib34","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.2174\/138161205774913426","article-title":"Phosphodiesterase type 5 inhibitors: molecular pharmacology and interactions with other phosphodiesterases","volume":"11","author":"Seftel","year":"2005","journal-title":"Curr. Pharm. Des."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846723002731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846723002731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:14:48Z","timestamp":1778742888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846723002731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":34,"alternative-id":["S0303846723002731"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2023.107857","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasodilatory effects of tadalafil in an animal model of cerebral vasospasm: Comparative analysis with oral nimodipine","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2023.107857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107857"}}